pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 18·1 min read
save

STAT Health Tech examines whether wearables benefit cardiovascular patients

Jun 18, 2026·read at STAT ↗Neutral

Mario Aguilar writes in a STAT Health Tech newsletter that the issue of wearables for people with cardiovascular disease is under review. The piece notes that researchers have been studying whether continuous monitoring via consumer devices can improve outcomes, but it does not present specific trial results or definitive conclusions.

The article serves as an overview of the topic, highlighting the growing interest in digital health tools and the regulatory and reimbursement questions that accompany them. It also points readers to the broader STAT Health Tech newsletter for ongoing coverage.

Readers are invited to subscribe to the twice‑weekly newsletter for more analysis on health technology, including AI, Medicare payment policies, and other emerging trends.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Do wearables actually help people with cardiovascular disease?”

read at STAT ↗
430 words · retrieved Jun 18
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Cardiology4Psychiatry & CNS2HematologyType 2 Diabetes

related stories

  • Jul 28After PCOS became PMOS, there’s hope for new awareness among Black and Latina womenSTAT
  • Jul 18Opinion: STAT readers on the value of primary care, obesity as a disease, and moreSTAT
  • Jul 1412 ideas for tackling the U.S. alcohol epidemicSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 9Dexcom RCT suggests CGM benefits for broad diabetes populationSTAT